Selective inhibition of mTORC1 through deletion of the RagC/D guanosine triphosphatase–activating protein folliculin arm of mTORC1 has been recently shown to inhibit de novo lipogenesis and protect mice from NAFLD (40). This evidence concerns the gene RRAGC and metabolic dysfunction-associated steatotic liver disease.